An Open Label SLV308 Safety Extension to Study S308.3.002 in Patients With Parkinson's Disease Experiencing Motor Fluctuations.

Completed · Phase 3

Conditions studied: Advanced Stage Parkinson's Disease

In brief

This study is a multicenter, 9 months, open label extension study for all patients who are willing and eligible to continue from the pivotal, double-blind S308.3.002 study.

Key facts

Study ID
NCT00407095
Run by
Solvay Pharmaceuticals
People needed
140
Starts
2007-08-01
Expected to finish
2009-05-01
Last updated by the study team
2010-09-13

Who can join

Age: 30 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.